glp-1 gip therapies muscle preservation 2025 New Enhance Quality of Weight Loss by Improving Tirzepatide for Medical Weight Loss

At the systemic level, GLP-1 RAs improve insulin sensitivity in peripheral tissues (muscle, adipose), reduce circulating free fatty acid flux to the liver, suppress hypothalamic appetite circuits to promote weight loss, and lower systemic pro-inflammatory cytokines (TNF-, IL-1, IL-6), thereby reducing the hepatic inflammatory milieu indirectly [7,26,30]

Patients on metformin and another antihyperglycemic agent (N=229) and patients not on any antihyperglycemic agents (off therapy for at least 8 weeks, N=41) were randomized after a run-in period of approximately 10 weeks on metformin (at a dose of at least 1500 mg per day) in monotherapy

Regulatory agencies may need to consider populationspecific monitoring recommendations as the use of GLP1RAs continues to expand

Iacobellis G, Mohseni M, Bianco SD, Banga PK

Reflux of stomach acid can cause throat soreness, burning sensations, and hoarseness in some patients

Historically, treatment options have been limited to lifestyle modificationspecifically weight loss of 710% of body weight, which can improve hepatic steatosis and inflammation